About P&T JournalContacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
Vice President, Group Publisher
Production: Mary Ellen Curry,
Director of Production Services
Circulation: Jackie Ott, Circulation Manager
Statement of Purpose
Guidelines for Authors
Although nursing homes have gotten better at reducing the number of elderly residents with pain, many of these patients still remain undertreated. More research is needed to manage pain in the elderly, who are often hesitant to speak up about their pain.
The author discusses advances in treatment, including cetuximab (Erbitux) for colorectal cancer, dasatinib (Sprycel) for chronic myeloid leukemia, enzastaurin as well as platinum combinations with pemetrexed (Alimta) and gemcitabine (Gemzar) for non–small-cell lung cancer, denileukin diftitox (Ontak) for T-cell lymphoma, and capecitabine (Xeloda) with bevacizumab (Avastin) for metastatic breast cancer.
Editors: David B. Nash, MD, MBA, Alexandria Skoufalos, EdD, Megan Hartman, MS, and Howard Horwitz, MPH
Reviewed by Alan T. Kaell, MD
Continuing Education Credit
Calcium and Vitamin D in the Prevention and Treatment of Osteoporosis: Shedding Light on New Developments
The authors review the physiological role of calcium and vitamin D, the differences in oral supplements, intake requirements, and the effect of these nutrients on bone mineral density and the risk of fractures.
Ian B. Hollis, PharmD, BCPS, and Randolph E. Regal, BS, PharmD
David Nash, MD, MBA, reviews On Call in Hell, a book about a Navy doctor in Iraq, and relates some important lessons about communication and cooperation in medical practice.
David B. Nash, MD, MBA
Matthew Grissinger, RPh, FASCP, explains how patients from various ethnic backgrounds respond to medications in diverse ways.
Matthew Grissinger, RPh, FASCP
Stephen Barlas discusses problems associated with the ever-increasing number of medication guides (MedGuides) that are given to patients when they receive their prescribed drugs.
P&T presents the latest studies and information about FDA approvals, drug indications, and industry updates.
Authors Antonopoulos, Lee, and Chang review ranolazine (Ranexa) for stable angina.
Marilena S. Antonopoulos, PharmD, Julie N. Lee, BSMT, PharmD, and Albert V. Chang, BS, PharmD